What is genetic research?
Through our genetic research program, we’ve been able to make incredible progress in identifying different types of prostate cancer at diagnoses. Prostate cancer is a complex disease. Genetic research has the power to revolutionise the diagnosis, treatment and prognosis of each prostate cancer patient.
We are now able to deliver a world-leading, intensive genomic analysis of a large cohort of Australian men with high-risk disease.
The international projects we’re working on will deliver a number of outcomes that can significantly improve the care of men with lethal prostate cancer and yield new prognostic biomarkers which can discriminate between low risk and lethal disease.
Our genetic research will lead to the development of tests to identify and differentiate between low-risk and high-risk prostate cancer. We will do this with participating clinical partners to allow the technology to be commercialised and accessed globally. The benefits for Australian men with lethal prostate cancer (and their families) will be that their care will significantly improve in the following ways:
For all newly diagnosed Australian men with prostate cancer, 51% have no benefit from treatment and 17% die regardless of treatment. Genetic research can dramatically improve these numbers.